Godavari Drugs Limited

Equities

GODAVARI6

INE362C01012

Pharmaceuticals

Market Closed - Bombay S.E. 11:00:56 31/05/2024 BST 5-day change 1st Jan Change
93 INR +2.14% Intraday chart for Godavari Drugs Limited -0.27% +3.26%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Godavari Drugs Limited Appoints Dinesh Udpa as Non-Executive-Independent Director CI
Godavari Drugs' Profit Flat in Fiscal Q2 MT
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Godavari Drugs Limited Announces Resignation of Ramesh Babu Telugu from the Post of Independent Director CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Godavari Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Godavari Drugs Limited Approves the Appointment of Mr. Venkatesh Achanta as Company Secretary CI
Godavari Drugs Limited Announces Executive Changes CI
Godavari Drugs Limited Announces Resignation of Mrs. Rashmi Agarwal as Company Secretary and Compliance Officer CI
Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Godavari Drugs Limited Appoints Mahendra Uday Bhalerao as Non-Executive Independent Director CI
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Godavari Drugs Limited Announces Resignation of Mr. Dilip Keshavlal Patel from Post of Non-Executive Independent Director CI
Godavari Drugs Limited Approves the Appointment of Mahindra Uday Bhalerao as Additional Independent Director CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Godavari Drugs' CFO Resigns MT
Godavari Drugs Limited Announces Resignation of Kirti Kumar Jain from the CFO CI
Godavari Drugs Limited Announces the Resignation of Kirti Kumar Jain from the Office of Whole-Time Director CI
Godavari Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Godavari Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Godavari Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Godavari Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Godavari Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Godavari Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Chart Godavari Drugs Limited
More charts
Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and its intermediates. The Company is engaged in the business of contract manufacturing, loan license manufacturing, manufacturing and supply of API, drug intermediaries and fine chemicals. The Company operates through manufacture and sale of API and its intermediates segment. The Company's manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The facility has multiple production blocks for API’s, drug intermediates and fine chemicals.
More about the company